× Home About us Contact Us Contributor Guidelines – All Perfect Stories Register Submit Your Stories
COVID 19
By EVASIONE SHEDIR PHARMA 2,479 views
HEALTH

Evasione Shedir Pharma Work on Coronavirus treatment Drug

More than 110 countries with records of coronaviruses cases. Thousands infected and many losing their lives to the virus. This new infectious virus officially called COVID-19 is making its way across the globe and rocking the whole planet earth.

Not only that, the health practitioners pharmaceutical companies, research organizations, and biotech industries generally found themselves in a tight corner. No vaccines yet in sight. No antiviral treatment has been proven to be effective. And well, the biotech industries are not giving up either.

Something has to be done and fast. When this novel coronavirus finds its way into a person’s respiratory system. It can be severe, Fatale and even deadly.

The good news is, the treatment of this infection, and vaccines to reduce the spread are brimming on the horizon. With the aggressive approach being employed, we are probably not far fetched from getting the solution. Here is, shedir pharma, a renowned pharmaceutical company based in Italy might be cooking something up. Not deterred by the Evasione Shedir Pharma, which has already been defined not to be true, this company is contributing to the noble cause to work on coronavirus treatment drugs. Who knows? This might be what the world needs to the pandemic coronavirus.

Steps adopted by the health practitioners so far to prevent the widespread of coronavirus

Mainly the health officials are adopting quarantines as a means of curtailing the virus spread. This has been so far effective considering that it also as a successful record while it was being used to stop the spread of SARS in 2004.

However, the need for a treatment drug and vaccine still remains indispensable.

Hence, in China alone, there have been 300 clinical trials already for the treatment of the sick patient. Moreover, the first Covid-19 vaccine is also said to be ready for clinical trials by the end of April.

It usually takes years if not, decades to get the standard treatment or vaccine. Nobody is ready to wait for that long as thousands of death cases have been reported worldwide already.

Thanks to the rise in technology and the records of excellence in developing treatment of other respiratory diseases such as SARS including HIV, influenza, and Ebola. The biotech industry, both pharmaceutical companies, and researchers are not only looking for new ways to put the old drugs to new use but also hasten the development of new vaccines and treatment of COVID-19.

Drugs for Coronavirus that is being Developed

Gilead Sciences’ Remdesivir has gained some recognition and has been commended by WHO to be quite effective in the treatment of the coronavirus infection.

This is an anti-viral drug that has made remarkable success in the treatment in lab and animal studies against infectious diseases such as SARS, Ebola, including COVID-19.

The drug was once administered on some patients with Ebola and was said not to have any negative side effects. The reports so far about have also been positive so far and more are still to be expected.  The New England Journal of Medicine (NEJM), said COVID-19 patients administer redeliver in the US are shown some improvement in the medical condition.

Actemra by Roche,  Favilavir, also an antiviral drug, are also some of the other drugs that have been approved in China to be used in the treatment of coronavirus patients.

Can Shedir Pharma Coronavirus Treatment Drugs be the way out?

Shedir pharma has recently started the development of a drug for the treatment of coronavirus. It has partnered with research institutions while leveraging cutting edge technology to hasten the process. The company is garnering efforts to identify molecules that can be effective in the treatment of the infection. With arms crossed, we watch out for more of what this company has to offer.

Evasione Shedir Pharma
Author
EVASIONE SHEDIR PHARMA

La maxi evasione shedir Pharma non è stata accertata dalla Guardia di Finanza che ha dovuto fare un passo indietro dopo pochi giorni dalla notizia perché la questione non era provata e già definita da tempo da parte della shedir pharma.